Enzalutamide + Rifampin Interaction
Moderateinteraction on record
Description
Strong CYP3A4 inducer that decreases plasma concentrations of enzalutamide and N-desmethyl enzalutamide, may decrease efficacy. Avoid coadministration; if unavoidable, increase XTANDI dosage.
Mechanism
CYP3A4 induction
Source: NLP:enzalutamide